查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1615307

口蹄疫疫苗市場：依產品、類型、應用和分銷管道分類－2025-2030年全球預測

Foot & Mouth Disease Vaccines Market by Product (Conventional, Emergency), Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年口蹄疫疫苗市場規模為26.9億美元，預計2024年將達29.3億美元，複合年成長率為9.10%，2030年將達49.5億美元。

口蹄疫 (FMD) 疫苗市場包括保護牲畜免受口蹄疫 (FMD) 感染的疫苗的開發、生產和分銷，口蹄疫是一種影響有蹄類動物的高度傳染性病毒性疾病。這些疫苗的需求源於口蹄疫的快速傳播以及對動物健康和貿易的嚴重影響，它可能會嚴重擾亂農業經濟和糧食安全。口蹄疫疫苗用於牛、綿羊、豬、山羊等多種牲畜，最終用途主要集中在獸醫院、專業畜牧研究所和農場，用於控制和預防疫情。市場洞察揭示了幾個成長要素，包括牲畜數量的增加、對畜產品的需求增加以及政府對口蹄疫疫苗的嚴格監管。該市場的潛在機會包括疫苗開發的技術進步，例如生產多種口蹄疫血清型的多效價疫苗，以及疫苗接種不足地區的疫苗接種覆蓋範圍，例如擴大目標市場。抓住這些機會的研究包括投資於提高疫苗功效和保存期限的研究，以及與當地農業部建立夥伴關係以提高市場滲透率。然而，該市場也存在局限性，包括疫苗儲存和分發的成本高昂，以及向農村牲畜所有者提供疫苗的後勤挑戰。此外，FMD 病毒株的突變使疫苗配方變得複雜。重組疫苗的開發和用於早期檢測口蹄疫疫情的增強診斷工具等領域的創新可能會取得進展，從而能夠更強力地應對疫情並推動市場成長。該市場的特點是快速成長，但由於疾病爆發而定期波動，因此需要持續的研究、政府支持和適應策略來維持市場發展。

主要市場統計
基準年[2023] 26.9億美元
預計年份 [2024] 29.3億美元
預測年份 [2030] 49.5億美元
複合年成長率（%） 9.10%

市場動態：快速發展的口蹄疫疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變口蹄疫疫苗市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球口蹄疫盛行率和發生率不斷上升
    • 政府制定強制疫苗接種政策以促進動物健康
  • 市場限制因素
    • 對熱不穩定性和免疫壽命縮短的擔憂
  • 市場機會
    • 加大口蹄疫疫苗研發投入
    • 政府增加對口蹄疫疫苗的核准
  • 市場挑戰
    • 與野生菌株重組的風險

波特五力戰略工具駕馭口蹄疫疫苗市場

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解口蹄疫疫苗市場的外部影響

外部宏觀環境因素對口蹄疫疫苗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解口蹄疫疫苗市場競爭狀況

對口蹄疫疫苗市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 口蹄疫疫苗市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估口蹄疫疫苗市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了口蹄疫疫苗市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對口蹄疫疫苗市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球口蹄疫的發生率和發生率均呈上升趨勢
      • 政府是否有強制疫苗接種政策以促進動物健康？
    • 抑制因素
      • 對熱不穩定性和短期免疫力的擔憂
    • 機會
      • 增加研發投資，打造先進的口蹄疫疫苗
      • 政府對口蹄疫疫苗的核准增加
    • 任務
      • 與野生菌株重組的風險
  • 市場區隔分析
    • 產品：緊急疫苗的使用迅速增加，為意外疾病的入侵提供快速解決方案
    • 通路：獸醫診所分銷口蹄疫疫苗的演變
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 口蹄疫疫苗市場：依產品

  • 傳統的
  • 緊急狀況

第7章 口蹄疫疫苗市場：依類型

  • DNA疫苗
  • 去活化疫苗
  • 減毒活疫苗
  • 活性病毒載體疫苗
  • 胜肽疫苗

第8章 口蹄疫疫苗市場：依應用分類

  • 牛
  • 山羊
  • 豬
  • 羊

第9章 口蹄疫疫苗市場：依通路分類

  • 政府機構
  • 獸醫診所

第10章 美洲口蹄疫疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區口蹄疫疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲口蹄疫疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 印度免疫學公司將在海德拉巴基因谷建造新的口蹄疫疫苗設施
    • Biogenesis Bago 在對抗口蹄疫方面取得了新的里程碑
    • 印尼開始在全國接種口蹄疫疫苗
  • 戰略分析和建議

公司名單

  • Bharatbiotech International Ltd.
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Botswana Vaccine Institute
  • Brilliant Bio Pharma
  • Brilliant Bio Pharma Pvt. Ltd.
  • China Animal Husbandry Group
  • Indian Immunologicals Ltd.
  • Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  • Inovio Pharmaceuticals, Inc.
  • Jinyu Baoling Biopharmaceutical Co., Ltd.
  • Laboratorios Bago SA
  • Limor de Colombia
  • Merck KGaA
  • Merial SAS
  • MorphoSys AG
  • QYH Biotech Co., Ltd.
  • Shenlian Biopharmaceutical（Shanghai）Co., Ltd.
  • Vallee SA
  • Vetal Animal Health Products SA
  • Veterinary Serum and Vaccine Research Institute
Product Code: MRR-4316E4E8956A

The Foot & Mouth Disease Vaccines Market was valued at USD 2.69 billion in 2023, expected to reach USD 2.93 billion in 2024, and is projected to grow at a CAGR of 9.10%, to USD 4.95 billion by 2030.

The scope of the Foot & Mouth Disease (FMD) vaccines market encompasses the development, production, and distribution of vaccines that protect livestock against FMD, a highly contagious viral disease affecting cloven-hoofed animals. The necessity for these vaccines stems from FMD's potential to significantly disrupt agricultural economies and food security due to its rapid transmission and severe implications for animal health and trade. The application of FMD vaccines ranges across various livestock, such as cattle, sheep, pigs, and goats, with end-use focused primarily on veterinary hospitals, specialized livestock research institutes, and farms to control and prevent outbreaks. Market insights reveal several growth factors, including increasing livestock population, rising demand for animal products, and stringent governmental regulations mandating FMD vaccines. Potential opportunities in this market include technological advancements in vaccine development, such as the production of multivalent vaccines that offer protection against multiple FMD serotypes, and expanding vaccine coverage geographically in regions lacking sufficient vaccine accessibility. Recommendations for capturing these opportunities involve investing in research to enhance vaccine efficacy and shelf life and forging partnerships with local agricultural ministries to broaden market penetration. However, the market also faces limitations, such as high costs associated with vaccine storage and distribution and logistical challenges in reaching rural livestock owners. Additionally, variations in FMD virus strains complicate vaccine formulation. Innovation can thrive in areas such as developing recombinant vaccines and enhancing diagnostic tools for early detection of FMD outbreaks, which would provide more robust responses to outbreaks and contribute to market growth. The market is characterized by rapid growth with periodic volatility due to disease outbreaks, thus reinforcing the need for continual research, governmental support, and adaptive strategies to sustain market advancement.

KEY MARKET STATISTICS
Base Year [2023] USD 2.69 billion
Estimated Year [2024] USD 2.93 billion
Forecast Year [2030] USD 4.95 billion
CAGR (%) 9.10%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Foot & Mouth Disease Vaccines Market

The Foot & Mouth Disease Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence and incidence of FMD outbreaks across the globe
    • Availability of government policies for mandatory vaccinations that promote animal health
  • Market Restraints
    • Concerns related to thermal instability and short-lived immunity
  • Market Opportunities
    • Increasing investments in R&D to yield advanced vaccines for FMD
    • Growing government approvals for FMD vaccines
  • Market Challenges
    • Risk of recombination with the wild strains

Porter's Five Forces: A Strategic Tool for Navigating the Foot & Mouth Disease Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Foot & Mouth Disease Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Foot & Mouth Disease Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Foot & Mouth Disease Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Foot & Mouth Disease Vaccines Market

A detailed market share analysis in the Foot & Mouth Disease Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Foot & Mouth Disease Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Foot & Mouth Disease Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Foot & Mouth Disease Vaccines Market

A strategic analysis of the Foot & Mouth Disease Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Foot & Mouth Disease Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bharatbiotech International Ltd., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Botswana Vaccine Institute, Brilliant Bio Pharma, Brilliant Bio Pharma Pvt. Ltd., China Animal Husbandry Group, Indian Immunologicals Ltd., Inner Mongolia Biwei Antai Biotechnology Co., Ltd., Inovio Pharmaceuticals, Inc., Jinyu Baoling Biopharmaceutical Co., Ltd., Laboratorios Bago S.A., Limor de Colombia, Merck KGaA, Merial S.A.S., MorphoSys AG, QYH Biotech Co., Ltd., Shenlian Biopharmaceutical (Shanghai) Co., Ltd., Vallee S.A., Vetal Animal Health Products S.A., and Veterinary Serum and Vaccine Research Institute.

Market Segmentation & Coverage

This research report categorizes the Foot & Mouth Disease Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Conventional and Emergency.
  • Based on Type, market is studied across DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Live Viral Vector Vaccines, and Peptide Vaccines.
  • Based on Application, market is studied across Cattle, Goat, Pigs, and Sheep.
  • Based on Distribution Channel, market is studied across Government Institutions and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence and incidence of FMD outbreaks across the globe
      • 5.1.1.2. Availability of government policies for mandatory vaccinations that promote animal health
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to thermal instability and short-lived immunity
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D to yield advanced vaccines for FMD
      • 5.1.3.2. Growing government approvals for FMD vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of recombination with the wild strains
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Burgeoning utilization of emergency vaccines offering a quick solution to unexpected incursions of the disease
    • 5.2.2. Distribution Channel: Evolving veterinary clinics for the distribution of foot and mouth disease vaccines
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Foot & Mouth Disease Vaccines Market, by Product

  • 6.1. Introduction
  • 6.2. Conventional
  • 6.3. Emergency

7. Foot & Mouth Disease Vaccines Market, by Type

  • 7.1. Introduction
  • 7.2. DNA Vaccines
  • 7.3. Inactivated Vaccines
  • 7.4. Live Attenuated Vaccines
  • 7.5. Live Viral Vector Vaccines
  • 7.6. Peptide Vaccines

8. Foot & Mouth Disease Vaccines Market, by Application

  • 8.1. Introduction
  • 8.2. Cattle
  • 8.3. Goat
  • 8.4. Pigs
  • 8.5. Sheep

9. Foot & Mouth Disease Vaccines Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Government Institutions
  • 9.3. Veterinary Clinics

10. Americas Foot & Mouth Disease Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Foot & Mouth Disease Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Foot & Mouth Disease Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Indian Immunologicals' new facility for FMD vaccines to come up in Hyderabad's Genome Valley
    • 13.3.2. Biogenesis Bago reaches a new milestone in its fight against Foot and Mouth Disease
    • 13.3.3. Indonesia launching nationwide vaccinations for foot and mouth disease
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bharatbiotech International Ltd.
  • 2. Biogenesis Bago SA
  • 3. Boehringer Ingelheim International GmbH
  • 4. Botswana Vaccine Institute
  • 5. Brilliant Bio Pharma
  • 6. Brilliant Bio Pharma Pvt. Ltd.
  • 7. China Animal Husbandry Group
  • 8. Indian Immunologicals Ltd.
  • 9. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  • 10. Inovio Pharmaceuticals, Inc.
  • 11. Jinyu Baoling Biopharmaceutical Co., Ltd.
  • 12. Laboratorios Bago S.A.
  • 13. Limor de Colombia
  • 14. Merck KGaA
  • 15. Merial S.A.S.
  • 16. MorphoSys AG
  • 17. QYH Biotech Co., Ltd.
  • 18. Shenlian Biopharmaceutical (Shanghai) Co., Ltd.
  • 19. Vallee S.A.
  • 20. Vetal Animal Health Products S.A.
  • 21. Veterinary Serum and Vaccine Research Institute

LIST OF FIGURES

  • FIGURE 1. FOOT & MOUTH DISEASE VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FOOT & MOUTH DISEASE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FOOT & MOUTH DISEASE VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE VIRAL VECTOR VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOVERNMENT INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023